Loss of MAP3K15 correlates consistently with lower blood glucose and HbA1c levels, which are predictive measures of microvascular sequelae such as peripheral neuropathy, nephropathy, and retinopathy. The gene discussed is MAP3K15; the disease is peripheral neuropathy.